Antimicrobial susceptibility of CRE isolates and environmental culture
| Antibiotics/case | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | Environmental culture |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Amikacin | I | S | R | I | R | S | R | R | S | R | S |
| Imipenem | R | R | R | R | R | R | R | R | R | R | R |
| Ampicillin/sulbactam | R | R | R | R | R | R | S | R | R | R | R |
| Ampicilin | R | R | R | R | R | R | R | R | R | R | R |
| Trimethoprim/sulfamethoxazole | S | R | R | I | R | S | S | S | S | S | S |
| Ceftazidime | R | R | R | R | R | R | R | R | R | R | R |
| Ticarcillin/clavulinicacid | R | R | R | R | R | R | R | R | R | R | R |
| Aztreonam | R | R | R | R | R | R | R | R | R | R | R |
| Ciprofloxacin | S | R | I | S | S | S | S | I | S | S | I |
| Cefazolin | R | R | R | R | R | R | R | R | R | R | R |
| Cefotaxime | R | R | R | R | R | R | R | R | R | R | R |
| Gentamicin | S | R | R | S | R | R | R | R | R | R | R |
| Amoxacillin/clavulinicacid | R | R | R | R | R | R | R | R | R | R | R |
| Cefuroxime | R | R | R | R | R | R | R | R | R | R | R |
Korean J healthc assoc Infect Control Prev 2022;27:43~50 https://doi.org/10.14192/kjicp.2022.27.1.43
© Korean J healthc assoc Infect Control Prev